ADTRAN Holdings, Inc.
ADTRAN Holdings, Inc. (ADTN) Financial Performance & Income Statement Overview
Analyze ADTRAN Holdings, Inc. (ADTN) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
ADTRAN Holdings, Inc. (ADTN) Income Statement & Financial Overview
Explore comprehensive income reports for ADTRAN Holdings, Inc. ADTN, broken down by year and quarter.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $247.74M | $242.85M | $227.70M | $225.99M |
Cost of Revenue | $152.57M | $151.62M | $142.45M | $144.42M |
Gross Profit | $95.18M | $91.23M | $85.25M | $81.58M |
Gross Profit Ratio | $0.38 | $0.38 | $0.37 | $0.36 |
R&D Expenses | $48.86M | $49.21M | $51.62M | $60.39M |
SG&A Expenses | $50.28M | $57.16M | $57.62M | $59.49M |
Operating Expenses | $99.14M | $106.36M | $109.23M | $119.88M |
Total Costs & Expenses | $251.71M | $257.98M | $251.69M | $264.30M |
Interest Income | $126000.00 | $1.63M | $664000.00 | $366000.00 |
Interest Expense | -$4.76M | $4.87M | $5.68M | $6.91M |
Depreciation & Amortization | $21.60M | $22.56M | $23.27M | $22.77M |
EBITDA | $17.01M | $8.83M | $477000.00 | -$15.20M |
EBITDA Ratio | $0.07 | $0.04 | $0.002 | -$0.07 |
Operating Income | -$3.97M | -$15.13M | -$23.98M | -$38.31M |
Operating Income Ratio | -$0.02 | -$0.06 | -$0.11 | -$0.17 |
Other Income/Expenses (Net) | -$5.38M | -$3.47M | -$4.48M | -$6.57M |
Income Before Tax | -$9.35M | -$18.60M | -$28.47M | -$44.88M |
Income Before Tax Ratio | -$0.04 | -$0.08 | -$0.13 | -$0.20 |
Income Tax Expense | -$397000.00 | $24.91M | $390000.00 | $2.14M |
Net Income | -$11.27M | -$45.92M | -$31.24M | -$49.87M |
Net Income Ratio | -$0.05 | -$0.19 | -$0.14 | -$0.22 |
EPS | -$0.14 | -$0.58 | -$0.40 | -$0.63 |
Diluted EPS | -$0.14 | -$0.58 | -$0.40 | -$0.63 |
Weighted Avg Shares Outstanding | $79.53M | $79.09M | $78.95M | $78.85M |
Weighted Avg Shares Outstanding (Diluted) | $79.53M | $79.09M | $78.95M | $78.85M |
Over the past four quarters, ADTRAN Holdings, Inc. demonstrated steady revenue growth, increasing from $225.99M in Q2 2024 to $247.74M in Q1 2025. Operating income reached -$3.97M in Q1 2025, maintaining a consistent -2% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $17.01M, reflecting operational efficiency. Net income rose to -$11.27M, with EPS at -$0.14. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan